TITLE

Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry

AUTHOR(S)
Bruscas, Ma. Jesús; Nieto, José; Perez-Pinar, Monserrat; López-Jiménez, Luciano; Fernández-Capitán, Carmen; López-Chuliá, Francisca; Orue-Lecue, Ma.
PUB. DATE
July 2007
SOURCE
Annals of Hematology;Jul2007, Vol. 86 Issue 7, p519
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The objective was to assess the use of suboptimal doses (60–149 UI kg−1 day−1) of low molecular weight heparin (LMWH) in the treatment of acute venous thromboembolism (VTE) in actual clinical practice and to evaluate the outcomes compared to standard doses (≥150 UI kg−1 day−1). Retrospective analysis of data from a multicenter registry of patients with VTE (RIETE; Registro Informatizado de Enfermedad TromboEmbólica). Patient characteristics, antithrombotic treatments, and 3-month outcomes were analyzed. We studied 12,302 patients with VTE; 10,524 patients were treated initially only with LMWH; 1,547 patients received suboptimal LMWH (mean = 122 UI kg−1 day−1), and 8,977 patients received full-dose LMWH (mean = 191 UI kg−1 day−1). The suboptimal group included significantly more patients with recent major bleeding, weight more than 100 kg, raised creatinine, or deep vein thrombosis. No significant differences in mortality rate (7.7 vs 7.8%), VTE recurrence (2.7 vs 2.3%), or fatal hemorrhage (0.6 vs 0.6%) occurred between the suboptimal and the standard group. Major bleeding episodes occurred more frequently in the patients with pulmonary embolism treated with suboptimal LMWH (4.5 vs 2.4%; p = 0.02). In the multivariate analysis, after adjusting for bleeding risk factors, major hemorrhage was not associated with the heparin dose. Suboptimal doses of LMWH are used in actual clinical practice in a reduced group of patients at an outcome rate not very different to that of standard doses. Bleeding episodes depend more on the patient’s characteristics than on the LMWH dose. Randomized trials should be performed to corroborate these results.
ACCESSION #
25137996

 

Related Articles

  • Clinical Experience with Ximelagatran in Orthopaedic Surgery. Eriksson, Bengt // Drugs;2004 Supplement 1, Vol. 64, p27 

    Patients who undergo orthopaedic surgery are at substantially increased risk for venous thromboembolic events. These include proximal and distal deep vein thrombosis, with the former more likely to lead to pulmonary embolism and fatal complications. Anticoagulants are routinely used for venous...

  • Evidence-Based Medicine Requires Appropriate Clinical Context. McNutt, Robert A.; Livingston, Edward H. // JAMA: Journal of the American Medical Association;2/3/2010, Vol. 303 Issue 5, p454 

    The authors comment on a study which examined the occurrence of venous thromboembolism (VTE) in patients with a single negative whole-leg compression ultrasound (CUS) result who did not receive anticoagulation. The meta-analysis of 7 studies, published within the issue, suggests that withholding...

  • Review: Low-molecular-weight heparin reduces recurrent venous thromboembolism better than unfractionated heparin.  // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p71 

    This article presents a study, which reports that low-molecular-weight heparin (LMVH) reduces recurrent venous thromboembolism (VTE) better than unfractionated heparin (UFH). The study method consisted of randomized controlled trials that compared fixed-dose subcutaneous LMWH with adjusted-dose...

  • Thromboembolism: unfractionated heparin revisited.  // PharmaWatch: Monthly Review;Oct2006, Vol. 5 Issue 10, p15 

    The article reports on a study that discusses the efficacy of the fixed-dose subcutaneous unfractionated heparin (UFH) to treat the acute venous thromboembolism. It is found that UFH is as effective as fixed-dose low-molecular-weight heparin (LMWH) and did not require the monitoring of blood...

  • Prevalence of Short Partial Thromboplastin Times in a Military Treatment Facility. Smith, Jordan D.; Amundson, Dennis E.; Harrell, Travis // Military Medicine;Aug2011, Vol. 176 Issue 8, p956 

    Background: It was recently noted that a shortened activated partial thromboplastin time (aPTT) is associated with increased venous thromboembolic events. The prevalence of aPTT shortening remains unknown. Methods: We conducted a retrospective analysis of aPTT results over a 2-month period....

  • Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar. Locke, Charles F. S.; Dooley, John; Gerber, Jonathan // Thrombosis Journal;2005, Vol. 3, p4 

    With the growing use of low-molecular-weight heparins (LMWH) for the treatment and prevention of venous thromboembolism (VTE), it is important to provide an evidence-based comparison with unfractionated heparin (UFH) concerning rates of heparin-induced thrombocytopenia (HIT). Such comparisons...

  • Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation. Hron, Gregor; Kollars, Marietta; Binder, Bernd R.; Eichinger, Sabine; Kyrle, Paul A. // JAMA: Journal of the American Medical Association;7/26/2006, Vol. 296 Issue 4, p397 

    Context Screening of patients with venous thromboembolism (VTE) for thrombo- philic risk factors is common clinical practice. Because of the large number of risk factors, assessing the risk of recurrence in an individual patient is complex. A method covering multicausal thrombophilia is...

  • ORAL ANTICOAGULATION RELATED INTRACEREBRAL HEMORRHAGE: MORE QUESTIONS THAN ANSWERS. Terecoasa, Elena; Tiu, Cristina; Huertas, Nuria; de Leciñana, Maria Alonso // Romanian Journal of Neurology;2012, Vol. 11 Issue 1, p13 

    Intracranial hemorrhage (ICH) is the most feared and devastating complication of oral anticoagulant therapy. When an ICH occurs, the patient's situation hinges on the balance between how great is the embolic risk while not receiving anticoagulants, and how big is the threat of the hemorrhage if...

  • Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia. Weintraub, Adi Y.; Sheiner, Eyal // Archives of Gynecology & Obstetrics;Dec2007, Vol. 276 Issue 6, p567 

    The aim of this review was to discuss the effectiveness of anticoagulant therapy and thromboprophylaxis in patients with thrombophilia. A MEDLINE search was performed using the keywords: “anticoagulant therapy”, “pregnancy”, “thromboprophylaxis”,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics